Angiotensin (AGT) Protein

Este producto es parte de AGT - Angiotensinogen
Product Graph
312€ (1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Angiotensin (AGT) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx073017

Description

Angiotensin Enzyme is an enzyme.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Angiotensin (AGT)
Host
Synthetic
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Purity
> 98% (RP-HPLC)
Size 1
1 mg
Size 2
10 mg
Size 3
200 mg
Form
Lyophilized 
Availability
Shipped within 5-10 working days.
Storage
Store lyophilized below -18°C. After reconstitution, store at 4 °C for up to 1 week, or below -18°C for long-term storage. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P01019
Alias
ANHU,SERPINA8,hFLT1
Background
Protein AGT
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Angiotensinogen (AGT) is a protein primarily produced and secreted by the liver, although it is also synthesized by other tissues, including the kidney and adipose tissue. It serves as the precursor molecule for the renin-angiotensin system (RAS), a key regulatory pathway involved in blood pressure regulation, fluid balance, and electrolyte homeostasis. AGT is converted into angiotensin I by the enzyme renin, which is released by the kidneys in response to various stimuli, such as decreased blood pressure or sodium levels. Angiotensin I is further converted into angiotensin II by angiotensin-converting enzyme (ACE), leading to vasoconstriction, aldosterone release, and sodium reabsorption, ultimately raising blood pressure. Dysregulation of the RAS, including alterations in AGT levels, has been implicated in hypertension, cardiovascular disease, and kidney disorders. Therapeutic interventions targeting the RAS, such as ACE inhibitors and angiotensin receptor blockers, are commonly used to manage hypertension and related conditions. Understanding the role of AGT in the RAS provides insights into cardiovascular health and potential avenues for therapeutic intervention. Ongoing research continues to elucidate the intricate mechanisms underlying AGT regulation and its implications for human health and disease

Related Products

EH0550

Human AGT(Angiotensinogen) ELISA Kit

Ver Producto
EM0458

Mouse Agt(Angiotensinogen) ELISA Kit

Ver Producto
EP0340

Porcine AGT(Angiotensinogen ) ELISA Kit

Ver Producto